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EMSOS Congress and Symposium of the Nurse Group Program
Wednesday, 22 May 2002
14:30–17:00 Registration of EMSOS and Nurse Group participants at the Faculty Club, Rapenburg 6 (Leiden city centre).
16:30–17:45 Joint welcome reception by the Mayor of Leiden and the Board of Leiden University at the Town Hall.
Thursday, 23 May 2002
08:00 Registration desk open and mounting of posters
EMSOS Congress Lecture Hall 1
08:30–08:40 President’s opening remarks
A. Diagnosis and treatment of borderline lesions
08:40–09:05 R. Fodde: Molecular background of desmoid tumours
09:05–10:15 Free Presentations
1 Desmoid tumors. A Clinical Review of 30 Patients with more than 20 years follow-up—Dalén
BPM, Goteborg, Sweden
2 Diagnostic impact of histologic parameters in differentiating enchondroma from grade I central
Chondrosarcoma—Hogendoorn PCW, Leiden, The Netherlands
3 BCL-2 Immunohistochemistry as a tool to distinguish osteochondroma and grade I peripheral
Chondrosarcoma—Bovee JVGM, Leiden, The Netherlands
4  The  treatment  of  benign  and  low-grade  malignant  intramedullary  chondroid  tumors  with
curettage and Cryosurgery—Schreuder HWB, Nijmegen, The Netherlands
5 The atypical Lipoma—Sommerville SMM, Birmingham, UK
10:15–10:45 Plenary selected poster review on borderline lesions: R. Veth
10:45–11:15 Coffee break and poster viewing
11:15–12:00 EMSOS lecture
J.C. Clevers: Fundamental mechanisms of tumourigenesis
12:00–12:15 Discussion
12:15–13:30 Lunch
B. Hereditary background in bone and soft-tissue tumours
13:30–13:55 M. Breuning: Overview of hereditary aspects of bone and soft-tissue tumours
13:55–15:15 Free presentations
22 Osteosarcoma subtypes in Osteosarcoma patients with multiple primary malignancies. Can rare
subtypes be indicative for cancer syndromes related with Osteosarcoma?—Hauben EI, Eindhoven,
The Netherlands
23 Gene and protein expression profiling in fibroblasts carrying a LI-Fraumeni p53 Germline muta-
tion that induces Chemoresistence to Doxorubicin—Sangiorgi L, Bologna, Italy
24  Somatic  and Germical  alteration  of  the  TP53  Gene  in  pediatric Osteosarcoma—Patiño  A,
Pamplona, Spain
25  Chromosome 9  alterations  and p16  expression in  Central Chondrosarcomas—Rozeman L,
Leiden, The Netherlands
26 Identification and clinical validation of candidate target Genes from the amplified Region on
Chromosome Arm 17Q in malignant peripheral nerve sheath tumours—Smeland S, Oslo, Norway
27 Association between the occurance of  Breast  Cancer and cartilaginous  tumors:  Phenotopic
characterization of a Hitherto unrecognized potential hereditary trait—Cleton-Jansen AM, Leiden,
The Netherlands
15:15–15:45 Tea break and poster viewing
15:45–16:15 Plenary selected poster review on hereditary tumours: Stefan S. BielackS4 EMSOS Program
C. Surgery and soft tissue tumours
16.15–17.15 Free presentations
79 Reliability of risk factors and scoring systems in predicting fracturing in metastatic femoral bone
lesions—Linden YM van der, Leiden, The Netherlands
80 Predictors of wound complications following free and pedicled soft tissue flaps for reconstruction
after  excision of soft tissue tumours—Abudu A, Birmingham, UK
81 Silver-coated tumor endoprostheses for prevention of deep infection—Gosheger G, Münster,
Germany
82 Our experience with the capanna method of Limb reconstruction  using free fibular grafts and
cadaveric allograft report of 16 consecutive patients—Bickels J, Tel Aviv, Israel
17:15–17:45 Plenary selected poster review on Surgery and soft tissue tumours
Symposium of the EMSOS Nurse Group Lecture Hall 2
08:45–09:00 Opening: Cristiana Forni
G. Long-term side-effects after treatment in young adult survivors of childhood cancer
09:00–09:40 Guest speaker: N.E. Langeveld
127 Quality of life in young adults who are long-term survivors of childhood Bone Cancer
09:40–09:50 Discussion
Moderators: M.A.M. Kroeze, J. Ouwerkerk
09:50–10:10 128 The hidden Long-term effects of treatment—Riley V, London,UK
10:10–10.30 129  Functional  outcome  following  Endo-prosthetic  replacement  (EPR)  for  Bone  Tumours
involving the Knee—Williams C, Birmingham, UK
10:30–11:00 Coffee break and poster viewing
H. Nursing care for patients treated with chemotherapy for bone tumours
11:00–11:20 130 A structured and effective way to inform Sarcoma Patients—Leyerzapf NAC, Leiden, The
Netherlands
11:20–11:40 131 Nursing care for patients treated with Chemotherapy for Bone Tumours the "Euro-Ewing 99"
Protocol—Ouwerkerk ED, Leiden, The Netherlands
11:40–12:00 132 How to inform the New Sarcoma Patient?—Forni C, Bologna, Italy
12:00–12.20 133 Wound healing deficiencies after Major Tumour Operations—Lübben K, Münster, Germany
12:20–12:30 Discussion
12:30–14:00 Lunch
I. Psychosocial aspects for patients and family members
14:00–14:20 134 The role of Lymphedema treatment in the rehabilitation after Limb-sparing Surgery—Meller I,
Tel Aviv, Israel
14.20–14.40 135  The  quality  of  interaction  between  the  operators,  the  Oncological  patient  and  his
family—Tanganelli F, Florence, Italy
14.40–15.00 136 Project for a school service—Forni C, Bologna, Italy
15.00–15.20 137 The experience of having Cancer—Woodford J, Middlesex, UK
15:20–15:45 Tea break and poster viewing
15:45–16:30 Guest speaker: N. Donders
138 The relation between Osteosarcoma, skiing and holidays for kids
16.30 Closing remarks
Friday, 24 May, 2002
EMSOS Congress 
08:00–08:45 General assembly
08:45–09:00 Coffee break
D. Imaging of primary and recurrent tumours
09:00–09:25 J.L. Bloem: Imaging modalities of bone and soft-tissue tumoursEMSOS Program S5
09:25–10:30 Free communications
41 The role of functional nuclear scanning in the management of cartilaginous tumours—Choong
P, Melbourne, Australia
42 3-D imaging in planning and monitoring biological reconstructions in orthopaedic oncology: A
computer assisted approach. Future perspectives and preliminary results—Manfrini M, Bologna,
Italy
43  Value  of  dynamic contrast-enhanced  MR  imaging  in  diagnosing  and  classifying  peripheral
vascular malformations—Rijswijk CSP van, Leiden, The Netherlands
44 Hip and Sacroileac joint infitration in sarcoma around the pelvis based on imaging and patho-
anatomical correlation studies  and its  implications  on surgical strategy—Lindner NJ, Münster,
Germany
10:30–11:00 Coffee break and poster viewing
11:00–11:30 Plenary selected poster review on imaging: D. Vanel
11:30–11:50 Report of the Nurses’ Symposium
E. Chemotherapy and other
11:50–12:35 Free presentations
98 Comparison of Doxorubicine versus VP16-ifosfamide in addition of high dose methotrexate as
pre-operative  Chemotherapy  in  Osteosarcomas.  A  randomized  trial  by  the  French  Society  of
Pediatric Oncology—Brugières LB, Villejuif, France
99 Gene therapy of Osteosarcoma: Targeting Adenoviruses towards integrins increases transduction
efficiency and tumor cell kill in vitro and in vivo—Witlox MA, Amsterdam, The Netherlands
100  Ewing  tumor  (ET) of the Spine  –  experience of the cooperative Ewing’s  sarcoma studies
(EI)CESS 81–92—Ahrens S, Münster, Germany
12:35–13:45 Lunch
13:45–14:15 Plenary selected poster review on Chemo and other: P. Picci
14:15–15:00 Campanacci lecture
O. Steen Nielsen: Progress in the treatment of bone and soft-tissue tumours of the extremities
15:00–15:15 Discussion
15:15–15:45 Tea break and poster viewing
F. Upper extremity reconstructions
15.45–16.45 Free presentations
54 Resection in Primary-malignant scapula tumors—Taminiau AHM, Leiden, The Netherlands
55 Upper Limb reconstruction in Bone Sarcomas of childhood—Manfrini M, Bologna, Italy
56 Upper extremity reconstruction: Is Limb-salvage for Osteosarcoma of the proximal humerus a
“Safe” procedure?—Bielack S, Münster, Germany
57  Cemented  modular  prosthesis  in  the  proximal  humerus:  long  term  follow-up—Donati  M,
Bologna, Italy
16:45–17:15 Plenary selected poster review on upper extremity reconstructions: R. Grimer
17.15–17.45 Discussion
17.45–17.55 Closing remarks